# AngioDynamics Fundamentals

ANGO | Stock | ## USD 12.25 0.12 0.97% |

AngioDynamics fundamentals help investors to digest information that contributes to AngioDynamics' financial success or failures. It also enables traders to predict the movement of AngioDynamics Stock. The fundamental analysis module provides a way to measure AngioDynamics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AngioDynamics stock.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. AngioDynamics | Select Account or Indicator |

**M**this year, although the value of Direct Expenses will most likely fall to about 138.7

**M**.

## AngioDynamics Number of Shares Shorted Analysis

AngioDynamics' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up. 2019 | 2020 | 2021 | 2022 (projected) | |

Enterprise Value | 372.04 M | 857.27 M | 762.36 M | 763.57 M |

Average Equity | 573.31 M | 450.95 M | 430.62 M | 442.93 M |

Shares Shorted | = | Shorted by Public | + | by Institutions |

## Current AngioDynamics Number of Shares Shorted | 958.69 K |

Most of AngioDynamics' fundamental indicators, such as Number of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AngioDynamics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Compare to competition |

Based on the recorded statements, AngioDynamics has 958.69

**K**of outstending shares currently sold short by investors. This is 70.03% lower than that of the Health Care Equipment & Supplies sector and 70.12% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 79.63% higher than that of the company.## AngioDynamics Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining AngioDynamics's current stock value. Our valuation model uses many indicators to compare AngioDynamics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across AngioDynamics competition to find correlations between indicators driving AngioDynamics's intrinsic value. More Info.AngioDynamics is number one stock in gross profit category among related companies. It is number one stock in return on equity category among related companies . AngioDynamics Gross Profit is quite stable at the moment as compared to the past year. The company's current value of Gross Profit is estimated at 153.86 Million. Comparative valuation analysis is a catch-all model that can be used if you cannot value AngioDynamics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AngioDynamics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the AngioDynamics' earnings, one of the primary drivers of an investment's value.## AngioDynamics Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AngioDynamics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AngioDynamics could also be used in its relative valuation, which is a method of valuing AngioDynamics by comparing valuation metrics of similar companies.AngioDynamics is currently under evaluation in net income category among related companies.

## AngioDynamics Current Valuation Drivers

We derive many important indicators used in calculating different scores of AngioDynamics from analyzing AngioDynamics' financial statements. These drivers represent accounts that assess AngioDynamics' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of AngioDynamics' important valuation drivers and their relationship over time.

2017 | 2018 | 2019 | 2020 | 2021 | 2022 (projected) | ||

Net Income Per Employee | 14.27 K | 81.79 K | (207.91 K) | (39.44 K) | (34.93 K) | (35.85 K) | |

Revenue Per Employee | 300.69 K | 360.85 K | 329.29 K | 363.76 K | 416.08 K | 345.31 K | |

Average Assets | 700.51 M | 773.02 M | 685.35 M | 578.99 M | 551.45 M | 582.06 M | |

Earnings Before Interest Taxes and Depreciation Amortization EBITDA | 31.76 M | 10.55 M | (145.81 M) | (11.36 M) | (2.2 M) | (2.26 M) | |

Earnings Before Interest Taxes and Depreciation Amortization USD | 31.52 M | 88.76 M | (141.35 M) | (6.82 M) | 2.53 M | 2.59 M | |

Earnings before Tax | 5.3 M | 57.78 M | (168.13 M) | (36.05 M) | (29.95 M) | (30.74 M) | |

Average Equity | 530.01 M | 565.84 M | 573.31 M | 450.95 M | 430.62 M | 442.93 M | |

Enterprise Value | 814.5 M | 790.67 M | 372.04 M | 857.27 M | 762.36 M | 763.57 M | |

Free Cash Flow | 38.9 M | 34.32 M | (21.79 M) | 10.38 M | (22.9 M) | (23.5 M) | |

Invested Capital | 267.2 M | 174.35 M | 130.68 M | 105.4 M | 121.16 M | 155.38 M | |

Invested Capital Average | 204.92 M | 206.67 M | 95.12 M | 124.83 M | 125.48 M | 155.28 M | |

Market Capitalization | 774 M | 699.29 M | 384.86 M | 881.74 M | 761.25 M | 730.2 M | |

Tangible Asset Value | 306.98 M | 343.38 M | 196.56 M | 191.15 M | 199.31 M | 203.89 M | |

Working Capital | 110.73 M | 241.99 M | 101.47 M | 83.3 M | 69.02 M | 95.56 M |

## AngioDynamics Institutional Holders

Institutional Holdings refers to the ownership stake in AngioDynamics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AngioDynamics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AngioDynamics' value.Security Type | Shares | Value | ||

Zurcher Kantonalbank Zurich Cantonalbank | Common Shares | 5.3 K | 109 K | |

Zurcher Kantonalbank Zurich Cantonalbank | Common Shares | 5.3 K | 103 K | |

Zurcher Kantonalbank Zurich Cantonalbank | Common Shares | 5.3 K | 115 K | |

Zurcher Kantonalbank Zurich Cantonalbank | Common Shares | 5.3 K | 147 K | |

Zurcher Kantonalbank Zurich Cantonalbank | Common Shares | 5.3 K | 138 K | |

Zurcher Kantonalbank Zurich Cantonalbank | Common Shares | 5.3 K | 145 K | |

Zurcher Kantonalbank Zurich Cantonalbank | Common Shares | 5.3 K | 125 K |

## AngioDynamics Fundamentals

Return On Equity | (0.08) % | |||

Return On Asset | (0.0274) % | |||

Profit Margin | (0.10) % | |||

Operating Margin | (0.08) % | |||

Current Valuation | 502.35 M | |||

Shares Outstanding | 39.11 M | |||

Shares Owned by Insiders | 5.03 % | |||

Shares Owned by Institutions | 96.22 % | |||

Number of Shares Shorted | 958.69 K | |||

Price to Earning | 7.90 X | |||

Price to Book | 1.15 X | |||

Price to Sales | 1.48 X | |||

Revenue | 316.22 M | |||

Gross Profit | 164.93 M | |||

EBITDA | 88 K | |||

Net Income | (26.55 M) | |||

Cash and Equivalents | 24.56 M | |||

Cash per Share | 0.31 X | |||

Total Debt | 25 M | |||

Debt to Equity | 0.14 % | |||

Current Ratio | 2.28 X | |||

Book Value Per Share | 10.49 X | |||

Cash Flow from Operations | (7.19 M) | |||

Short Ratio | 1.79 X | |||

Earnings Per Share | (1.02) X | |||

Price to Earnings To Growth | 1.87 X | |||

Target Price | 26.5 | |||

Number of Employees | 760 | |||

Beta | 0.7 | |||

Market Capitalization | 474.38 M | |||

Total Asset | 552.75 M | |||

Retained Earnings | 64.54 M | |||

Working Capital | 79.53 M | |||

Current Asset | 146.25 M | |||

Current Liabilities | 66.73 M | |||

Z Score | 5.4 | |||

Net Asset | 552.75 M |

## About AngioDynamics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AngioDynamics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioDynamics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioDynamics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.Last Reported | Projected for 2022 | ||

Cost of Revenue | 150.5 M | 139 M | |

Revenues | 316.2 M | 292.6 M | |

Revenue to Assets | 0.57 | 0.50 | |

Revenue Per Employee | 416.1 K | 345.3 K |

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards AngioDynamics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, AngioDynamics' short interest history, or implied volatility extrapolated from AngioDynamics options trading.

## Pair Trading with AngioDynamics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AngioDynamics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AngioDynamics will appreciate offsetting losses from the drop in the long position's value.### Moving together with AngioDynamics

+ | 0.81 | EDIT | Editas Medicine | Downward Rally | PairCorr |

### Moving against AngioDynamics

- | 0.81 | DXCM | DexCom Inc | Downward Rally | PairCorr |

The ability to find closely correlated positions to AngioDynamics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AngioDynamics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AngioDynamics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AngioDynamics to buy it.

The correlation of AngioDynamics is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AngioDynamics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AngioDynamics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for AngioDynamics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Please continue to AngioDynamics Piotroski F Score and AngioDynamics Altman Z Score analysis. Note that the AngioDynamics information on this page should be used as a complementary analysis to other AngioDynamics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Share Portfolio module to track or share privately all of your investments from the convenience of any device.

## Complementary Tools for AngioDynamics Stock analysis

When running AngioDynamics price analysis, check to measure AngioDynamics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AngioDynamics is operating at the current time. Most of AngioDynamics' value examination focuses on studying past and present price action to predict the probability of AngioDynamics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move AngioDynamics' price. Additionally, you may evaluate how the addition of AngioDynamics to your portfolios can decrease your overall portfolio volatility.

Alpha FinderUse alpha and beta coefficients to find investment opportunities after accounting for the risk | Go | |

Share PortfolioTrack or share privately all of your investments from the convenience of any device | Go | |

Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | Go | |

Focused OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences | Go | |

Money Flow IndexDetermine momentum by analyzing Money Flow Index and other technical indicators | Go | |

Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. | Go | |

Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities | Go | |

Fundamental AnalysisView fundamental data based on most recent published financial statements | Go | |

Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | Go | |

Global CorrelationsFind global opportunities by holding instruments from different markets | Go |

Is AngioDynamics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AngioDynamics. If investors know AngioDynamics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AngioDynamics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Market Capitalization 474.4 M | Quarterly Revenue Growth YOY 0.059 | Return On Assets (0.0274) | Return On Equity (0.08) |

The market value of AngioDynamics is measured differently than its book value, which is the value of AngioDynamics that is recorded on the company's balance sheet. Investors also form their own opinion of AngioDynamics' value that differs from its market value or its book value, called intrinsic value, which is AngioDynamics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AngioDynamics' market value can be influenced by many factors that don't directly affect AngioDynamics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AngioDynamics' value and its price as these two are different measures arrived at by different means. Investors typically determine AngioDynamics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AngioDynamics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.